Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The lymphatic system in alcohol-associated liver disease

Reiichiro Kondo, Yasuko Iwakiri

Clin Mol Hepatol. 2020;26(4):633-638. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0179

View: 9882 Download: 162 Web of Science: 3 Crossref: 3

Review

The lymphatic vascular system in liver diseases: its role in ascites formation

Chuhan Chung, Yasuko Iwakiri

Clin Mol Hepatol. 2013;19(2):99-104. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.99

View: 11587 Download: 240 Web of Science: 65 Crossref: 67

Original Article

Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines

Sung Hoon Choi, Hye Won Shin, Jun Yong Park, Ji Young Yoo, Do Young Kim, Weon Sang Ro, Chae-Ok Yun, Kwang-Hyub Han

Clin Mol Hepatol. 2010;16(3):280-287. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.280

View: 9715 Download: 66 Crossref: 11

Editorial

Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis

Jin-Wook Kim

Clin Mol Hepatol. 2010;16(3):278-279. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.278

View: 6524 Download: 34 Crossref: 3

3

Expression of Caveolin in Hepatocellular Carcinoma: Association with Unpaired Artery Formation and Radiologic Findings

Ha Na Choi, M.S., Kyung Ryoul Kim, Ph.D., Ho Sung Park, M.D., Kyu Yun Jang, M.D., Myoung Jae Kang, M.D., Dong Geun Lee, M.D., Young Kon Kim, M.D. Baik Hwan Cho, M.D. Eun Jung Cha, M.D., Woo Sung Moon, M.D.

Clin Mol Hepatol. 2007;13(3):396-408. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.396

View: 6516 Download: 31 Crossref: 7

2

The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis

June Sung Lee , Jong Hoon Kim

Clin Mol Hepatol. 2007;13(3):309-319. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.309

View: 5669 Download: 61 Crossref: 12

Hypoxia in Hepatocellular Carcinoma

Sun Jung Myung , Jung Hwan Yoon

Clin Mol Hepatol. 2007;13(1):9-19. Published online January 1, 1970

View: 3351 Download: 24

7

Il Han Song

Clin Mol Hepatol. 2004;10(2):174-176. Published online January 1, 1970

View: 2634 Download: 14

3

The Role of Angiostatin, Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9 and 12 in the Angiogenesis of Hepatocellular Carcinoma

Sook Kim, M.D. Ho Sung Park, M.D., Hyun Jin Son, M.D. and Woo Sung Moon, M.D.

Clin Mol Hepatol. 2004;10(1):62-72. Published online January 1, 1970

View: 3171 Download: 25

Implications of Serum Levels of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor in Chronic Liver Diseases and Hepatocellular Carcinoma

Sung Jae Yoo, M.D, Sung Moon Jung, M.D, Jong Gwang Kim, M.D, Jin Ok Lee, M.D, Yong Whan Song, M.D, Chul Ju Han, M.D, Sook-Hyang Jung, M.D, You Cheoul Kim, M.D, Chang-Min Kim, M.D, Jhin Oh Lee, M.D, Young Joon Hong, M.D* and Seok Il Hong, M.D*

Clin Mol Hepatol. 2001;7(1):47-54. Published online January 1, 2000

View: 2576 Download: 20

1

Role of Angiogenic Factors during the Hepatocarcinogenesis

Young Nyun Park

Clin Mol Hepatol. 2001;7(1):12-14. Published online January 1, 2000

View: 2596 Download: 16

1 |

Viewed By 8997	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7682	MAFLD: How is it different from NAFLD?
Viewed By 5548	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5155	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4614	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 293	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 204	MAFLD: How is it different from NAFLD?
Cited By 103	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes

Search